For more information call (888) LUHS-888.
Participants must have histologically proven (T2, T3, or T4a) urothelial carcinoma of the bladder (UCB) that requires primary radical cystectomy for definitive treatment. Participants must not have clinical stage consistent with a low-risk of node metastasis (CIS only, T1). Patients with a T4b (fixed lesion) are not eligible for this study. There must be plans for a cystectomy and lymph node dissection (LND) within 28 calendar days following registration. Laparoscopic surgery is not allowed. Please see the protocol for additional requirements.
The purpose of this study is to compare the effects, good and/or bad, of performing a standard lymph node removal versus an extended lymph node removal.